J. Waters

In Vitro Human Immunodeficiency Virus Type 1 Resistance Selections with Combinations of Tenofovir and Emtricitabine or Abacavir and Lamivudine

M. D. Miller, N. Margot, J. Waters, 2006, Antimicrobial Agents and Chemotherapy.

In Vitro Human Immunodeficiency Virus Type 1 Resistance Selections with Combinations of Tenofovir and Emtricitabine or Abacavir and Lamivudine (cid:1)

N. Margot, M. Miller, J. Waters, 2006 .

Low-Level K65R Mutation in HIV-1 Reverse Transcriptase of Treatment-Experienced Patients Exposed to Abacavir or Didanosine

K. Borroto-Esoda, Lijie Zhong, E. Svarovskaia, 2007, Journal of acquired immune deficiency syndromes.

Baseline genotype as a predictor of virological failure to emtricitabine or stavudine in combination with didanosine and efavirenz.

K. Borroto-Esoda, J. Hinkle, J. Quinn, 2007, AIDS research and human retroviruses.

Mutations in the thumb–connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patients

K. White, K. Borroto-Esoda, E. Svarovskaia, 2009, Antiviral therapy.